This is an international site for Tasigna® (Nilotinib) and is intended for Health Care Professionals outside the U.S. The information on the site is not country-specific, and may contain information that is outside the approved indications in the country in which you are located. Please contact your local Novartis representative for the latest information specific to your country.

I am a healthcare professional outside the US I am a US resident I am a patient outside the US
Print Text Size Glossary Summary of Product Characteristics Safety Information U.S. Residents

This site is intended for Healthcare Professionals outside the U.S.

INTERACTIVE TOOLS

These tools are designed to help you learn more about BCR-ABL.

This mechanism of disease video will provide an overview of the role of BCR-ABL in Ph+ CML and how TKIs target the kinase to treat the disease.

BCR-ABL Mechanism of Disease Video
BCR-ABL Mechanism of Disease Video
Click to enlarge >>

In this interactive game you will create your own TKI by moving the nodes up and down to match the BCR-ABL binding pocket.


Interactive Game
TASIGNA Interactive Game
Click here to play the game>>

To learn more about RT-Q-PCR monitoring, visit the CML Alliance

View patient-friendly tips that can help improve adherence

Loading the player ...